4//SEC Filing
Hirsch Stanley 4
Accession 0001209191-19-055210
CIK 0001606645other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:32 PM ET
Size
8.2 KB
Accession
0001209191-19-055210
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2019-11-04$0.62/sh+32,500$20,150→ 182,500 total(indirect: See footnote) - Exercise/Conversion
Options
2019-11-04−32,500→ 0 total(indirect: See footnote)Exercise: $0.62From: 2004-01-01Exp: 2019-11-25→ Ordinary Shares (32,500 underlying)
Holdings
- 69,365
Ordinary Shares
Footnotes (2)
- [F1]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.
- [F2]This security represents ordinary shares and restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.
Documents
Issuer
Foamix Pharmaceuticals Ltd.
CIK 0001606645
Entity typeother
Related Parties
1- filerCIK 0001727864
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 4:32 PM ET
- Size
- 8.2 KB